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Abstract
Background: The measurement of follicular output rate (FORT) has been proposed as a 
good indicator for evaluating follicular response to the exogenous recombinant follicle-
stimulating hormone (rFSH). This places FORT as a promising qualitative marker for 
ovarian function.  The objective of the study was to determine FORT as a predictor of 
oocyte competence, embryo quality and clinical pregnancy after intracytoplasmic sperm 
injection (ICSI).    
Materials and Methods: This prospective study was carried out on a group of infer-
tile females (n=282) at Islamabad Clinic Serving Infertile Couples, Islamabad, Paki-
stan, from June 2010 till August 2013.  Down- regulated females were stimulated in 
injection gonadotropins and on ovulation induction day, pre-ovulatory follicle count 
(PFC) was determined using transvaginal ultrasound scan (TVUS), and FORT was 
determined as a ratio of PFC to antral follicle count (AFC)×100. Group I consisted of 
females with a negative pregnancy test, while group II had a positive pregnancy test 
that was confirmed with the appearance of fetal cardiac activity. Linear regression 
analyses of categorical variables of clinical pregnancy along with other independent 
variables, including FORT, were performed using SPSS version 15.0.
Results: Pregnancy occurred in 101/282 women who were tested, recording a clinical 
pregnancy rate of about 35.8%. FORT values were higher in group II as compared to 
group I females (P=0.0001). In multiple regression analysis, 97.7, 87.1, 78.2, and 83.4% 
variations were explained based on the number of retrieved oocytes per patients, number 
of metaphase II oocytes retrieved, number of fertilized oocytes, and number of cleaved 
embryos, respectively, indicating FORT as an independent predictor.
Conclusion: FORT is a predictor of oocyte competence in terms of a number of retrieved, 
mature and fertilized oocytes. It also gives information about the number of cleaved em-
bryos and clinical pregnancy rate.     
Keywords: Intracytoplasmic Sperm Injection, Assisted Reproductive Techniques, Infer-
tility, Ovarian Follicles, Follicular Output Rate  
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Introduction 
The prevalence of infertility in Pakistan is 
21.9%, which accounts for approximately 3.5 
to 3.9% cases of primary infertility and 18.0 to 
18.4% of secondary infertility (1). The assisted re-
productive clinics offer scientific assistance to in-
fertile couples for the commencement of pregnan-
cy preparation. Assisted reproductive techniques 
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include in vitro fertilization (IVF) and intracyto-
plasmic sperm injection (ICSI) for the treatment 
of infertile couples (2, 3).
In ICSI, after the down-regulation of ovaries, 
controlled ovarian hyperstimulation (COH) is fol-
lowed by ovulation induction (OI) and oocyte pick-
up, after which a single sperm is introduced in the 
ooplasm, placed under a microscope. The procedure 
has shown a greater success rate as compared to IVF. 
Ovarian stimulation is a key procedure necessary to 
achieve success in assisted reproductive techniques. 
Stimulation is achieved by the administration of ex-
ogenous gonadotropins in the form of recombinant 
follicle stimulating hormone (rFSH) in order to in-
crease the follicular recruitment and oocyte yield. 
Confirmation of responsiveness of ovarian reservoir 
to FSH in terms of the development of the antral 
follicles is so far a challenge for reproductive en-
docrinologists at clinics (1, 4). The appropriate re-
sponse of antral follicles to FSH and a high-quality 
oocyte may result in a positive impact on outcomes 
of IVF and ICSI. Poor response to COH results in 
retrieval of few oocytes with reduced number of 
embryos available for transfer, leading to a decrease 
in pregnancy rates (2). 
The endocrinologists, thus, devised various 
methods to assess the ovarian reservoir and the 
expected responsiveness. Antral follicle count 
(AFC) is one of the non- invasive methods used 
for the assessment of the sensitivity of antral fol-
licles to FSH (5). AFC represents the number of 
remaining primordial pool which corresponds to 
the number of oocytes retrieved; however, it does 
not influence the number of oocytes, embryo qual-
ity and the outcome of ICSI (6). The number of 
pre-ovulatory follicle count (PFC) obtained at the 
end of COH is estimated to be the best indicator of 
the number of retrieved oocytes (2, 3, 7).  
However, it also includes the number of small 
antral follicles available before treatment (8, 9). It 
means that follicular output rate (FORT) determines 
follicular response to exogenous rFSH by the ratio 
of pre-ovulatory follicles to the existing pool of 
small antral follicles. The index has been investi-
gated as an indicator of existing ovarian reservoir in 
response to stimulation and oocyte competence by 
a number of researchers (1, 4, 5). In addition to as-
sessing ovarian function, we designed this study in 
order to identify the value of FORT for the predic-
tion of oocyte competence, embryo quality and the 
likelihood of clinical pregnancy after ICSI.
Materials and Methods
This prospective study was carried out at Islama-
bad Clinic Serving Infertile Couples Islamabad, Pa-
kistan, between June 2010 and August 2013 after 
the ethical approval was obtained from the Ethical 
Review Board of Islamabad Clinic Serving Infer-
tile Couples, Islamabad, Pakistan. The study was 
conducted in accordance with the principles of the 
Declaration of Helsinki, and an informed written 
consent was taken from all study participants. The 
women (n=282) undergoing ICSI were included 
in this study with the following criteria: infertility 
duration of more than 2 years, age range of 21-40 
years, regular menstrual cycle, normal morphologi-
cal ovaries, body mass index (BMI) of 18-35 kg/
m2, and serum FSH levels lower than 8 IU/ml. The 
exclusion criteria were as follows: polycystic ovary 
syndrome (PCOS), uterine fibroids, down-regula-
tion with short gonadotropin-releasing hormone 
(GnRH)-agonist or -antagonist protocol, sperm re-
trieval by testicular biopsy, and use of IVF cycles. 
Treatment protocol 
The treatment protocol of females was carried 
out as mentioned by Rehman et al. (3). Total num-
ber of AFC with a mean diameter of 3-8 mm was 
determined using a transvaginal ultrasound scan 
(TVUS) with a 7.5 MHz probe (Aloka Co., Japan). 
COH was carried out using subcutaneous adminis-
tration of 50 IU/day rFSH (Puregon, NV Organon, 
The Netherlands). The initiation dose was calcu-
lated based on the of the age of the subject, basal 
serum FSH concentrations, AFC and BMI (6). Dose 
adjustment was done by follicular tracking with 
TVUS, commenced from the fifth day of COH on 
alternate days for assessment of follicular response 
and measurement of endometrial thickness. During 
the last days of COH, patients had to visit the as-
sisted reproductive clinics daily for the appropriate 
time of OI using human chorionic gonadotropin 
(hCG) injection (1). On OI day, PFC was calcu-
lated as the total number of follicles with a mean 
diameter of 16-22 mm in both ovaries using TVUS. 
The FORT was calculated as the ratio of PFC on 
OI day ×100/AFC (10). Approximately 37 hours 
after hCG injection, oocyte pick-up was performed 
under general anesthesia using a vaginal ultrasound 
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probe, after which luteal support was provided with 
the progesterone vaginal pessaries (Cyclogest 400 
mg, Actavis Co., UK) twice a day. Transfer of blas-
tocysts was performed seven days after hCG injec-
tion using Edwards-Wallace embryo replacement 
catheter (SIMS Portex Ltd., UK) under ultrasound 
guidance. Two blood samples were taken on days of 
hCG injection and blastocyst transfer for estimation 
of peak and mid-luteal levels of estradiol (E2) and 
progesterone using enzyme linked immuno sorbent 
assay (ELISA).  Serum E2 and progesterone as well 
as ELISA kits were provided by MP Biomedicals, 
USA and BioSource, Belgium, respectively.
Outcome parameters  
The marker for detection of pregnancy out-
come was beta-hCG (β-hCG) levels that were 
measured 14 days after egg collection. Clinical 
pregnancy was identified by the appearance of a 
gestational sac with cardiac activity using TVUS. 
Therefore, the participants were divided into the 
following groups: group I (n=181) including 
non-pregnant women with β-hCG<25 mIU/ml, 
and group II (n=101) including pregnant women 
with β-hCG>25 mIU/ml and the presence of car-
diac activity confirmed by TVUS. Pregnancy rate 
was calculated by the presence of an intrauterine 
gestational sac observed by TVUS per number of 
patients in the cycle (5, 7).  
Statistical analysis
Data was analyzed by Statistical Package for 
Social Science software (SPSS, SPSS Inc., USA) 
version 15.0. The stepwise backward method 
was used to estimate the best model using FORT 
as a predictor that was adjusted with other clini-
cal risk factors affecting clinical pregnancy out-
come, including female age, BMI, FSH, duration 
of infertility, the length of stimulation, AFC, and 
PFC. A variable is entered into the model if the 
significance level of its F value is less than 0.05 
and removed if the significance level is greater 
than 0.10. Four different models were developed 
showing that FORT gave significant effect on the 
number of oocytes/patient, the number of meta-
phase II oocytes retrieved, the number of cleaved 
embryos and number of fertilized oocytes. In re-
gression analysis, R-squared (R2, coefficient of 
determination) described variation in dependent 
variable with respect to independent variable(s), 
while Spearman’s Rank Correlation was used to 
investigate the correlation of clinical pregnancy 
with different parameters. A P value less than 0.05 
was considered to be statistically significant.
Results
Baseline characteristics of study participants are 
given in Table 1. Pregnancy occurred in 101/282 
women who were tested, recording a clinical 
pregnancy rate of about 35.8%. Table 2 explains 
the significant difference regarding FORT values 
in group I (49.31 ± 12.83) and II (64.17 ± 8.96).
Table 1: Baseline characteristics of the infertile subjects
Parameters Mean SD
Female age (Y)   32.18 4.72
Duration of infertility (Y) 7.46 4.01
Length of stimulation (days) 14.16 0.96
AFC 13.07 2.56
PFC 8.31 1.71
FORT 64.09 8.97
No. of oocytes/patient 8.21 1.53
No. of metaphase II oocytes 
retrieved 8.03 1.45
No. of fertilized oocytes 6.65 1.07
No. of cleaved embryos 6.56 1.04
Peak progesterone (ng/ml) 0.85 0.45
Mid-luteal progesterone (ng/ml) 89.17 32.84
Peak E2 (pg/ml) 2529.06 193.99
Mid-luteal  E2 (pg/ml) 1109.46 136.29
Endometrial thicknessa (mm) 1.74 0.44
Values are presented as mean ± SD. AFC; Antral follicle count,  PFC; Pre-
ovulatory follicle count, FORT; Follicular output rate, and E
2
; Estradiol.
Table 2: Comparison of the parameters between group I 
(non-pregnant participants) and group II (pregnant participants)
Parameters Non- 
pregnant
participants
n=181
Pregnant
participants
n=101
P value
Female age (Y) 32.11 ± 4.61 32.107 ± 4.74 0.952
Duration of 
infertility (Y) 6.94 ± 3.78 7.40 ± 4.02 0.409
Length of 
stimulation 
(days)
14.43 ± 0.96 14.15 ± 0.95 - 0.454
Dose of 
rFSH/day 3.89  ± 1.43 4.29  ± 2.96 <0.001
FORT Predicts ICSI Outcome
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Table 2: Continued
Parameters Non- 
pregnant
participants
n=181
Pregnant
participants
n=101
P value
AFC 15.57 ± 2.51 13.04 ± 2.55 0.559
PFC 7.52 ± 1.90 8.30 ± 1.69 0.364
FORT 49.31 ± 12.83 64.17 ± 8.96 <0.001
No.  of 
cleaved em-
bryos
5.45 ± 1.53 6.56 ± 1.03 <0.001
Endometrial 
thickness (mm)
1.26 ± 0.44 1.74 ± 0.43 0.819
No. of oocytes/
patient
7.40 ± 1.68 8.20 ± 1.51 0.296
No. of mature 
oocytes/patient 
6.61 ± 2.03 8.02 ± 1.43 0.004
No. of fertilized 
oocytes 
5.54 ± 1.64 6.65 ± 1.06 <0.001
Peak E2 (pg/ml) 2207.97 ± 283.73 2529.06 ± 193.35  <0.01
Mid-luteal E2 
(pg/ml)
899.49 ± 122.05 1109.46 ± 135.83  <0.01
Peak progester-
one (ng/ml) 
1.96 ± 0.67 1.12 ± 0.59 <0.01
Mid-luteal 
progesterone
ng/ml
192.44 ± 20.34 116.51 ± 48.60 <0.01
Values are presented as mean ± SD. rFSH; Recombinant folicle 
stimulating hormone, AFC; Antral follicle count, PFC; Pre ovula-
tory follicle count, FORT; Follicular output rate, and E
2
; Estradiol.  
It indicates that the length of stimulation, AFC (r=-
0.412, P<0.01), as well as peak (r=-0.640, P<0.01) 
and mid-luteal progesterone levels (r=-0.802, P<0.01) 
showed a significant negative association with clini-
cal pregnancy outcome.  However, FORT (r=0.532, 
P<0.001), PFC (r=0.265, P<0.01), number of cleaved 
embryos (r=0.365, P<0.01), peak (r=0.640, P<0.01) 
and mid-luteal (r=0.679, P<0.01), E2 (r=0.640, 
P<0.01) levels, as well as endometrial thickness 
(r=670, P<0.01) showed a significant positive correla-
tion with clinical pregnancy outcome (Table 3). Linear 
regression analysis of FORT as an independent predic-
tor described variations of 97.7, 87.1, 78.2 and 83.4% 
for the number of retrieved oocytes per patients, num-
ber of metaphase II oocytes retrieved, the number of 
fertilized oocytes, and the number of cleaved embryos, 
respectively (Table 4).  Furthermore, table 4 shows an 
increase in FORT value by one unit increased the mean 
number of oocytes/patients (β coefficient: 0.135), 
while the model was adjusted for length of stimula-
tion and AFC with an adjusted R2 value of 97.7%. The 
model describes that an increase in FORT value by one 
unit increased the mean number of metaphase II oo-
cytes retrieved (β coefficient: 0.128), while the model 
was adjusted for FSH and AFC with an adjusted R2 
value of 87.1%. The model also describes that an in-
crease in FORT value by one unit will give a positive 
impact on the mean number of oocytes fertilized (β 
coefficient: 0.089), while the model was adjusted for 
FSH and AFC with an adjusted R2 value of 78.2 %. 
However, the model suggested that one unit increase 
in FORT value decreased the mean number of cleaved 
embryos (β coefficient: -0.025), while it was adjusted 
for AFC and number of metaphase II oocytes retrieved 
(Table 4).
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Table 3: Comparison of the parameters for clinical pregnancy outcome using Spearman rank correlation
Predictors Clinical pregnancy r(P value)
Female age (Y) 0.001(0.981)
Duration of infertility (Y) 0.052(0.380)
Length of stimulation  (days) -0.140*(0.018)
AFC -0.412*(<0.01)
PFC 0.265*(<0.01)
FORT 0.532*(<0.01)
No. of cleaved embryos 0.365*(<0.01)
Peak progesterone (ng/ml) -0.652*(<0.01)
Mid luteal progesterone (ng/ml) -0.802*(<0.01)
Peak E2 (pg/ml) 0.640
*(<0.01)
Mid luteal E2 (pg/ml) 0.679
*(<0.01)
Endometrial thickness 0.628*(<0.01)
AFC; Antral follicle count, PFC; Pre-ovulatory follicle count, FORT; Follicular output rate, E
2
; Estradiol, *; Correlation with P<0.05 considered as significant, and 
r; Spearman rank correlation.
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Discussion
The successful outcome in assisted reproductive 
clinics depends on embryos and endometrial quali-
ties. The quality of embryos depends on number 
and quality of oocytes, which in turn is considered 
as a measure of antral follicles responsiveness to 
FSH; however, no pointer can predict both ovarian 
response and oocyte competence. FORT, in this re-
gard, can be used as an innovative marker to predict 
ovarian response and oocyte competence, leading to 
increase the chances of clinical pregnancy (8). 
AFC as a non-invasive method of assessment 
plays a key role in the prediction of ovarian re-
sponse and provides a valuable insight into the 
sensitivity of antral follicles to FSH (5). In this 
study, AFC showed significant negative associa-
tion with the pregnancy outcome.  Similar to our 
findings, a study reported that AFC represented 
the actual ovarian reserve and were highly cor-
related with the number of oocytes retrieved (6). 
Furthermore, other studies concluded that AFC 
cannot predict the oocyte/embryo quality or IVF/
ICSI outcome and showed better FORT results in 
subjects with decreased AFC (4, 11). A study de-
clared that AFC obtained at the end of stimulation 
is the best indicator of the number of retrieved 
oocytes and good clinical outcome (7). However, 
a contrasting observation was noted in another 
study where pre-ovulatory follicles were not ob-
served as an appropriate reflector of antral folli-
cle sensitivity to FSH (12). The conflict can thus 
be resolved by the use of FORT index, which can 
reflect ovarian follicular competence in response 
to stimulation (4, 5).
High FORT showed a higher rate of clinical 
pregnancies that can  be  explained on the basis of 
its association with basal, peak and mid-luteal E2 
concentrations (8). The role of high FORT in in-
creasing peak E2 concentrations can be explained 
by increased retrieval, maturity and fertilization of 
oocytes, which potentially lead to an increase in 
clinical pregnancy rate (10, 13, 14). Enhanced mid-
luteal E2 concentration in females with high FORT 
increases the chance of pregnancy, which is also 
supported by other studies (3-8, 15). 
The exact role of progesterone in determining the 
success of IVF/ ICSI is a subject of debate. Our re-
sults showed that females with high FORT had low 
peak progesterone levels, which is similar to another 
study in which pregnancy rate was inversely related 
to serum progesterone levels (16). However, in con-
trast to these results, a study proved that progester-
one enhances uterine receptivity by the maturation 
of mast cells that produce cytokines and growth 
factors (17, 18). Hofmann et al. (19) observed no 
significant difference in pregnancy rate in patients 
undergoing IVF/embryo transfer with high or low 
progesterone concentrations on the day of hCG ad-
ministration and in patients receiving oocytes do-
nated from women with high or low progesterone 
concentrations. The role of FORT in the prediction 
of clinical pregnancy can thus be emphasized on the 
basis of its effect on hormones of implantation. 
It seems that FORT is a qualitative indicator of 
ovarian follicles competence and has a significant 
correlation with the clinical pregnancy outcome. 
Our results showed that it has positive effects on 
a number of oocytes/patient, the number of meta-
phase II oocytes retrieved, the number of cleaved 
embryos and number of fertilized oocytes. Similar 
to other two studies that reflected the rates of good 
quality embryos and embryo implantations, clinical 
pregnancies increased dramatically in accordance 
with FORT values (4, 20). Besides the importance 
of the impact of FORT on clinical pregnancy, it was 
a unicentric study in which different sonologists 
determined AFC and PFC which must be standard-
FORT Predicts ICSI Outcome
Table 4: Regression models with FORT as an independent predictor
Regression models  Independent predictor Beta coefficient SE Adjusted R2 P value
No. of oocytes/patientsa FORT 0.135 ± 0.003 97.7% <0.01*
No. of metaphase II oocytes retrievedb FORT 0.128 ± 0.006 87.1% <0.01*
No. of fertilized  oocytesc FORT 0.089 ± 0.006 78.2% <0.01*
No. of cleaved embryosd FORT -0.025 ± 0.01 83.4% 0.019*
FORT; Follicular output rate, R2; Coefficient of  determination, AFC; Antral follicle count, FSH; Follicle stimulating hormone, a; Adjusted 
with length of stimulation and AFC, b, c; Adjusted with FSH and AFC, d; Adjusted with AFC and number of metaphase II oocytes retrieved 
and *; P<0.05 was considered as significant.
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ized for uniformity . The variation in marking AFC 
and PFC by different sonographers is unlikely to be 
ruled out.
Conclusion
FORT is a predictor of oocyte competence in terms 
of a number of retrieved, mature and fertilized oocytes. 
The indicator can be used for prediction of clinical 
pregnancy rate after ICSI. It also gives information 
about the number of cleaved embryos and clinical 
pregnancy rate which needs to be further explored.
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